Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?

The good times aren't over, but the peak of the party might be passing.Eli Lilly (LLY 4.28%) and Novo Nordisk (NVO -0.40%), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both declined even as the rest of the market rose.Short-term price changes shouldn't have anything to do with an investment thesis for either stock. Still, investors sold shares in both for a reason. And there's a chance that the issue driving ...